A Quadruplet Regimen Comprising Carfilzomib, Cyclophosphamide, Lenalidomide, Dexamethasone (KCRD) Vs an Immunomodulatory Agent Containing Triplet (CTD/CRD) Induction Therapy Prior to Autologous Stem Cell Transplant: Results of the Myeloma XI Study

Jackson, GH, Davies, FE, Pawlyn, C et al. (18 more authors) (2018) A Quadruplet Regimen Comprising Carfilzomib, Cyclophosphamide, Lenalidomide, Dexamethasone (KCRD) Vs an Immunomodulatory Agent Containing Triplet (CTD/CRD) Induction Therapy Prior to Autologous Stem Cell Transplant: Results of the Myeloma XI Study. In: Blood. 60th ASH Annual Meeting, 01-04 Dec 2018, San DIego, California, USA. American Society of Hematology , p. 302.

Metadata

Item Type:	Proceedings Paper
Authors/Creators:	Jackson, GH Davies, FE Pawlyn, C Cairns, D https://orcid.org/0000-0002-2338-0179 Striha, A https://orcid.org/0000-0003-3363-8417 Hockaday, A Collett, C Jones, JR Kishore, B Garg, M Williams, C Karunanithi, K Lindsay, J Jenner, M Cook, G https://orcid.org/0000-0003-0223-3652 Russell, NH Kaiser, M Drayson, MT Owen, RG Gregory, WM Morgan, G
Dates:	Published: 29 November 2018
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	05 May 2020 10:12
Last Modified:	29 Jun 2020 13:36
Status:	Published
Publisher:	American Society of Hematology
Identification Number:	10.1182/blood-2018-99-114956
Related URLs:	Author
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:159522

CORE (COnnecting REpositories)

A Quadruplet Regimen Comprising Carfilzomib, Cyclophosphamide, Lenalidomide, Dexamethasone (KCRD) Vs an Immunomodulatory Agent Containing Triplet (CTD/CRD) Induction Therapy Prior to Autologous Stem Cell Transplant: Results of the Myeloma XI Study

Metadata

Download not available

Export

Statistics